MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$405,313K
Cash and cash
equivalents
$128,513K
Gross carrying amount
$69,320K
Total cash, cash
equivalents, and marketable...
$533,826K
Other current assets
$111,113K
Accounts and accrued
receivable
$58,293K
Restricted cash
$25,000K
Property and equipment,
net
$428,003K
Investments in equity
accounted investees
$62,580K
Other long-term
assets
$51,948K
Goodwill
$47,806K
Intangible assets, net
$38,381K
Accumulated amortization
$30,939K
Total current assets
$728,232K
Total long-term
assets
$628,718K
Total assets
$1,356,950K
Total liabilities and
shareholders' equity
$1,356,950K
Total shareholders'
equity
$966,904K
Total liabilities
$390,046K
Accumulated earnings
(deficit)
-$29,482K
Accumulated other
comprehensive loss
-$4,234K
Common shares no par
value, unlimited...
$802,341K
Additional paid-in capital
$198,279K
Total long-term
liabilities
$325,739K
Total current
liabilities
$64,307K
Deferred government
contributions
$174,453K
Operating lease liability
$137,403K
Deferred tax liability
$9,115K
Other long-term
liabilities
$4,768K
Accounts payable and
other current...
$50,781K
Deferred revenue
$13,526K
Back
Back
Balance Sheet
source: myfinsight.com
AbCellera Biologics Inc. (ABCL)
AbCellera Biologics Inc. (ABCL)